ALLISON SMITH: Open Payments
NPI 1134872641 · WESLACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 31 payments from 10 companies in 2025. Trend: 2023 $717 · 2024 $633 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $471 |
| PFIZER INC. | 5 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $84 |
| Boston Scientific Corporation | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Medtronic, Inc. | 2 | $53 |
| Amgen Inc. | 3 | $52 |
| SCPHARMACEUTICALS INC. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $16 |
Products named: CARDIOMEMS, ELIQUIS, JARDIANCE, CDS - MCT/CEM Monitoring, Kerendia, ESPRIT, REPATHA, FUROSCIX.
Industry payments across TX — which companies pay providers there.
